312 related articles for article (PubMed ID: 32599890)
1. Endometriosis-Associated Ovarian Cancer: The Origin and Targeted Therapy.
Murakami K; Kotani Y; Nakai H; Matsumura N
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32599890
[TBL] [Abstract][Full Text] [Related]
2. RUNX3 is inactivated by promoter hypermethylation in malignant transformation of ovarian endometriosis.
Guo C; Ren F; Wang D; Li Y; Liu K; Liu S; Chen P
Oncol Rep; 2014 Dec; 32(6):2580-8. PubMed ID: 25333219
[TBL] [Abstract][Full Text] [Related]
3. [Epigenetic inactivation of SPOCK2 in the malignant transformation of ovarian endometriosis].
Ren F; Wang DB; Li T
Zhonghua Fu Chan Ke Za Zhi; 2011 Nov; 46(11):822-5. PubMed ID: 22333230
[TBL] [Abstract][Full Text] [Related]
4. How Does Endometriosis Lead to Ovarian Cancer? The Molecular Mechanism of Endometriosis-Associated Ovarian Cancer Development.
Yachida N; Yoshihara K; Yamaguchi M; Suda K; Tamura R; Enomoto T
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33809880
[TBL] [Abstract][Full Text] [Related]
5. Differences in LINE-1 methylation between endometriotic ovarian cyst and endometriosis-associated ovarian cancer.
Senthong A; Kitkumthorn N; Rattanatanyong P; Khemapech N; Triratanachart S; Mutirangura A
Int J Gynecol Cancer; 2014 Jan; 24(1):36-42. PubMed ID: 24304685
[TBL] [Abstract][Full Text] [Related]
6. Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer.
Er TK; Su YF; Wu CC; Chen CC; Wang J; Hsieh TH; Herreros-Villanueva M; Chen WT; Chen YT; Liu TC; Chen HS; Tsai EM
J Mol Med (Berl); 2016 Jul; 94(7):835-47. PubMed ID: 26920370
[TBL] [Abstract][Full Text] [Related]
7. Aberrant expression of genes associated with stemness and cancer in endometria and endometrioma in a subset of women with endometriosis.
Ponandai-Srinivasan S; Andersson KL; Nister M; Saare M; Hassan HA; Varghese SJ; Peters M; Salumets A; Gemzell-Danielsson K; Lalitkumar PGL
Hum Reprod; 2018 Oct; 33(10):1924-1938. PubMed ID: 30020448
[TBL] [Abstract][Full Text] [Related]
8. Rare but Still There: A Scoping Review on Endometriosis-Associated Ovarian Cancer.
Livori K; Calleja-Agius J
Discov Med; 2024 Mar; 36(182):467-481. PubMed ID: 38531788
[TBL] [Abstract][Full Text] [Related]
9. Endometriosis-associated ovarian cancer occurs early during follow-up of endometrial cysts.
Murakami K; Kotani Y; Shiro R; Takaya H; Nakai H; Matsumura N
Int J Clin Oncol; 2020 Jan; 25(1):51-58. PubMed ID: 31473885
[TBL] [Abstract][Full Text] [Related]
10. Integrating modern approaches to pathogenetic concepts of malignant transformation of endometriosis.
Kobayashi H; Yamada Y; Kawahara N; Ogawa K; Yoshimoto C
Oncol Rep; 2019 Mar; 41(3):1729-1738. PubMed ID: 30592289
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for endometriotic-cyst associated ovarian cancer: A case controlled study.
Udomsinkul P; Triratanachart S; Oranratanaphan S
Taiwan J Obstet Gynecol; 2020 Mar; 59(2):269-274. PubMed ID: 32127149
[TBL] [Abstract][Full Text] [Related]
12. The ARID1A pathway in ovarian clear cell and endometrioid carcinoma, contiguous endometriosis, and benign endometriosis.
Chene G; Ouellet V; Rahimi K; Barres V; Provencher D; Mes-Masson AM
Int J Gynaecol Obstet; 2015 Jul; 130(1):27-30. PubMed ID: 25912412
[TBL] [Abstract][Full Text] [Related]
13. Elevated RON protein expression in endometriosis and disease-associated ovarian cancers.
Xu P; Ding S; Zhu L; Le F; Huang X; Tian Y; Zhang X
Arch Gynecol Obstet; 2017 Mar; 295(3):631-639. PubMed ID: 27888297
[TBL] [Abstract][Full Text] [Related]
14. Cyst fluid iron-related compounds as useful markers to distinguish malignant transformation from benign endometriotic cysts.
Yoshimoto C; Iwabuchi T; Shigetomi H; Kobayashi H
Cancer Biomark; 2015; 15(4):493-9. PubMed ID: 25835178
[TBL] [Abstract][Full Text] [Related]
15. Histopathology and ARID1A Expression in Endometriosis- Associated Ovarian Carcinoma (EAOC) Carcinogenesis Model with Endometrial Autoimplantation and DMBA Induction.
Wuyung PE; Rahadiati FB; Tjahjadi H; Salinah S; Kusmardi K; Kodariah R; Wiweko B
Asian Pac J Cancer Prev; 2021 Feb; 22(2):553-558. PubMed ID: 33639673
[TBL] [Abstract][Full Text] [Related]
16. Endometriosis-associated ovarian cancer: a review of pathogenesis.
Worley MJ; Welch WR; Berkowitz RS; Ng SW
Int J Mol Sci; 2013 Mar; 14(3):5367-79. PubMed ID: 23466883
[TBL] [Abstract][Full Text] [Related]
17. The High Expression of RRM2 Can Predict the Malignant Transformation of Endometriosis.
Yang B; Wang T; Li N; Zhang W; Hu Y
Adv Ther; 2021 Oct; 38(10):5178-5190. PubMed ID: 34424503
[TBL] [Abstract][Full Text] [Related]
18. Evidence for the Relationship Between Endometriosis and Epithelial Ovarian Cancer.
del Carmen MG
Obstet Gynecol Surv; 2015 Sep; 70(9):587-95. PubMed ID: 26403563
[TBL] [Abstract][Full Text] [Related]
19. Understanding malignant transformation of endometriosis: imaging features with pathologic correlation.
Robinson KA; Menias CO; Chen L; Schiappacasse G; Shaaban AM; Caserta MP; Elsayes KM; VanBuren WM; Bolan CW
Abdom Radiol (NY); 2020 Jun; 45(6):1762-1775. PubMed ID: 30941451
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological characteristics, molecular features and novel diagnostic strategies for the detection of malignant transformation of endometriosis (Review).
Kobayashi H
Exp Ther Med; 2023 Jun; 25(6):279. PubMed ID: 37206546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
